|
市場調査レポート
商品コード
1293978
カスタム抗体の世界市場:タイプ別、サービス別、由来別、研究分野別、エンドユーザー別、用途別 - 2023年~2030年の予測Custom Antibody Market by Type, Service, Source, Research Area, End Users, Application - Russia Ukraine Conflict and High Inflation - Global Forecast 2023-2030 |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。 |
カスタム抗体の世界市場:タイプ別、サービス別、由来別、研究分野別、エンドユーザー別、用途別 - 2023年~2030年の予測 |
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 192 Pages
納期: 即日から翌営業日
|
世界のカスタム抗体の市場規模は大きく成長し、2023年にはCAGR19.90%で4億763万米ドルとなり、2030年までに14億9,758万米ドルに達すると予測されています。
FPNVポジショニングマトリックスは世界のカスタム抗体市場を評価するために不可欠です。事業戦略や製品満足度などの主要指標を検証することで、ベンダーの包括的な評価を提供し、ユーザーが特定のニーズに基づいて情報に基づいた意思決定を行えるようにします。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。
市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。
本レポートは、以下のポイントに関する洞察を提供します:
1.市場の浸透度:主要企業が提供する市場に関する包括的な情報を提供します。
2.市場の発展:有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。
3.市場の多様化:新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。
4.市場の動向:COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。
5.競合の評価と情報:主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。
6.製品開発およびイノベーション:将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。
本レポートは、以下のような質問にお答えします:
1.カスタム抗体の世界市場規模および予測は?
2.予測期間中、カスタム抗体の世界市場を形成するCOVID-19の阻害要因と影響は?
3.カスタム抗体の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は?
4.カスタム抗体の世界市場における競争戦略は?
5.カスタム抗体の世界市場における技術動向と規制の枠組みは?
6.カスタム抗体の世界市場における主要ベンダーの市場シェアは?
7.カスタム抗体の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか?
The Global Custom Antibody Market is forecasted to grow significantly, with a projected USD 407.63 million in 2023 at a CAGR of 19.90% and expected to reach a staggering USD 1,497.58 million by 2030.
The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Custom Antibody Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.
Based on Type, market is studied across Monoclonal Antibodies, Polyclonal Antibodies, and Recombinant Antibodies. The Monoclonal Antibodies commanded largest market share of 34.46% in 2022, followed by Polyclonal Antibodies.
Based on Service, market is studied across Antibody Development, Antibody Fragmentation & Labeling, and Antibody Production & Purification. The Antibody Development commanded largest market share of 31.34% in 2022, followed by Antibody Production & Purification.
Based on Source, market is studied across Mice and Rabbit. The Rabbit commanded largest market share of 34.56% in 2022, followed by Mice.
Based on Research Area, market is studied across Cardiovascular Diseases, Immunology, Infectious Diseases, Neurobiology, Oncology, and Stem cells. The Oncology commanded largest market share of 21.45% in 2022, followed by Immunology.
Based on End Users, market is studied across Academic & Research Institutes, Contract Research Organizations, Hospitals & Clinics, and Pharmaceutical & Biotechnology Companies. The Pharmaceutical & Biotechnology Companies commanded largest market share of 47.34% in 2022, followed by Contract Research Organizations.
Based on Application, market is studied across Research and Therapeutics. The Research commanded largest market share of 61.46% in 2022, followed by Therapeutics.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 37.10% in 2022, followed by Europe, Middle East & Africa.
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.
The FPNV Positioning Matrix is essential for assessing the Global Custom Antibody Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).
The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Custom Antibody Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Custom Antibody Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Custom Antibody Market?
4. What is the competitive strategic window for opportunities in the Global Custom Antibody Market?
5. What are the technology trends and regulatory frameworks in the Global Custom Antibody Market?
6. What is the market share of the leading vendors in the Global Custom Antibody Market?
7. What modes and strategic moves are considered suitable for entering the Global Custom Antibody Market?